Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,520
Ph III recruiting: 168
Growth YoY: +6.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,319)

clinicaltrialsPublishedShowing 451–500 of 517 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03303547	Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits(COMET)	recruiting	N/A	200	Imperial College LondonOTHER	1	Oct 17, 2024	clinicaltrials
NCT04049214	Perioperative Mindfulness Proposal	recruiting	N/A	24	Hoag Memorial Hospital PresbyterianOTHER	1	Oct 15, 2024	clinicaltrials